The usage of radio(active) tracers is what makes nuclear medicine unique, by allowing assessment of metabolism at the cellular level. These tracers, however, are complex to produce, transport and handle, and they decay over time. This is why PET-CT scans are one of the most expensive medical imaging techniques, limiting its broad usage. 

Novel radiotracers and treatments for oncology have boosted demand for PET scans, increasing the workload of PET centres, resulting in ever longer waiting times for patients. 

With our hybrid solution, patient data is stored on a secure and centralized server, while our AI algorithms are managed from the cloud, so they can be reliably updated and maintained. No need for additional hardware.

Our vendor-agnostic software solutions fit seamlessly in your existing workflow: you can keep using your existing diagnostic viewer. 

Faced with an ever-increasing volume of nuclear imaging studies, it is challenging for doctors to maintain the same quality of assessment. There is always a risk of human error in the interpretation of such images. 

We are developing solutions that will act as a second pair of eyes, detecting metastatic lesions and other abnormalities in your studies. Using our tools will increase your workflow efficiency while maintaining diagnostic quality and confidence.